Purpose of Review <p>To provide an updated, comprehensive overview of diffuse cystic lung diseases (DCLDs), highlighting diagnostic and therapeutic advancements and identifying opportunities for future investigations.</p> Recent Findings <p>We review the six main subcategories of DCLD – Lymphangioleiomyomatosis, Pulmonary Langerhans Cell Histiocytosis, Birt-Hogg-Dubé, Lymphoid Interstitial Pneumonia, Cystic Amyloidosis, and Light Chain Deposition Disease – along with other disease processes that may manifest as DCLD, including certain infections, malignancies, and genetic conditions. We outline the unique presentations, pathogenesis, diagnostic features, and management of these conditions. We also review recent updates in DCLD research, which primarily focus on exploring new diagnostic mechanisms and therapies for these rare conditions.</p> Summary <p>DCLD is a unique disease category that warrants further attention to strengthen clinicians’ confidence in caring for affected individuals and to expand diagnostic and treatment modalities available to this population.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Diffuse Cystic Lung Disease – Updates and Opportunities for Advancement

  • Meghan K. Lóser,
  • Bonnie R. Wang

摘要

Purpose of Review

To provide an updated, comprehensive overview of diffuse cystic lung diseases (DCLDs), highlighting diagnostic and therapeutic advancements and identifying opportunities for future investigations.

Recent Findings

We review the six main subcategories of DCLD – Lymphangioleiomyomatosis, Pulmonary Langerhans Cell Histiocytosis, Birt-Hogg-Dubé, Lymphoid Interstitial Pneumonia, Cystic Amyloidosis, and Light Chain Deposition Disease – along with other disease processes that may manifest as DCLD, including certain infections, malignancies, and genetic conditions. We outline the unique presentations, pathogenesis, diagnostic features, and management of these conditions. We also review recent updates in DCLD research, which primarily focus on exploring new diagnostic mechanisms and therapies for these rare conditions.

Summary

DCLD is a unique disease category that warrants further attention to strengthen clinicians’ confidence in caring for affected individuals and to expand diagnostic and treatment modalities available to this population.